Newmed Energy Limited Partnership

As of June 30, 2026, Newmed Energy Limited Partnership carries a market capitalization of 1.83T, placing it among publicly traded companies globally. Its enterprise value stands at 2.24T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Newmed Energy Limited Partnership's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, Newmed Energy Limited Partnership has 1.17B shares outstanding.

As of June 30, 2026, Newmed Energy Limited Partnership trades at a trailing price-to-earnings ratio of 23.46. The price-to-sales ratio is 6.24, and the price-to-book ratio stands at 3.29.

As of June 30, 2026, Newmed Energy Limited Partnership trades at an EV/EBITDA multiple of 11.37 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 7.65 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 18.74 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Newmed Energy Limited Partnership trades at an EV/FCF ratio of 63.62, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 2.24T versus a market cap of 1.83T, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Newmed Energy Limited Partnership maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 83.15, indicating elevated leverage, while an interest coverage ratio of 7.47 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Newmed Energy Limited Partnership posted a return on equity (ROE) of 14.08, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 8.32 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.58, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.56, useful for judging operating efficiency across full business cycles. The company generates approximately 12.36B in revenue per employee across its workforce of 23.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Newmed Energy Limited Partnership recorded 34.00B in income tax expense. That works out to an effective tax rate of 29.77, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 114.20B, leaving 78.04B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Newmed Energy Limited Partnership's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 1,640.64, while the 200-day moving average is 1,781.48.

Over the twelve months ended June 30, 2026, Newmed Energy Limited Partnership generated 293.58B in revenue and converted that into 78.04B in net income, yielding earnings per share of 68.29. EBITDA reached 197.43B, while operating income came in at 120.63B.

As of June 30, 2026, Newmed Energy Limited Partnership holds 48.55B in cash and equivalents against 462.35B in total debt, resulting in a net debt position of 446.79B. Total book value stands at 556.04B, with working capital of -44.10B providing operational flexibility.

Newmed Energy Limited Partnership produced 119.18B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -102.46B in capital expenditures, free cash flow totaled 16.72B - equivalent to 14.24 per share.

Over the twelve months ended June 30, 2026, Newmed Energy Limited Partnership posted a gross margin of 42.54, reflecting its pricing power and cost economics. The operating margin of 41.09 and net profit margin of 26.58 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Newmed Energy Limited Partnership paid dividends of 63.20 per share. The dividend payout ratio of 92.50 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.91, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.39, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Newmed Energy Limited Partnership shareholders.

Newmed Energy Limited Partnership's most recent stock split took place on March 2, 2003.

As of June 30, 2026, Newmed Energy Limited Partnership has an Altman Z-Score of 2.85, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.